These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 14473616

  • 1. [1st observations on the use of spirolactones (synthetic anti-aldosterone steroids) in pregnancy nephropathies].
    MIGLIAVACCA A, BOMPIANI A.
    Gynecol Obstet (Paris); 1961; 60():443-50. PubMed ID: 14473616
    [No Abstract] [Full Text] [Related]

  • 2. [EFFECT OF A SPIRONOLACTONE ALDOSTERONE INHIBITOR AND CHLOROTHIAZIDE ON WATER AND ELECTROLYTE EXCRETION IN LIVER DISEASES].
    PERISIC V, KONECNI J, BANICEVIC B.
    Srp Arh Celok Lek; 1964 Mar; 92():301-8. PubMed ID: 14242671
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of aldosterone secretion and modification of electrolyte excretion in man by a chemical inhibitor of 11 beta-hydroxylation.
    COPPAGE WS, ISLAND D, SMITH M, LIDDLE GW.
    J Clin Invest; 1959 Dec; 38(12):2101-10. PubMed ID: 13811859
    [No Abstract] [Full Text] [Related]

  • 4. Effects of antialdosterone compounds (spirolactones) on the antinatruresis of the upright position in pregnancy.
    LONGO LD, ASSALI NS.
    Surg Gynecol Obstet; 1960 Jun; 110():673-5. PubMed ID: 14418164
    [No Abstract] [Full Text] [Related]

  • 5. ELECTROLYTE EXCRETION BY SWEAT GLANDS AND KIDNEYS DURING SUPPRESSION OF ADRENAL CORTICOSTEROID ACTIVITY BY METHOPYRAPONE AND SPIRONOLACTONE.
    MAY CD.
    Am J Dis Child; 1965 Jan; 109():2-8. PubMed ID: 14222418
    [No Abstract] [Full Text] [Related]

  • 6. [ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)].
    POLIANTSEVA LR, ERMOLENKO VM.
    Sov Med; 1963 Dec; 27():42-51. PubMed ID: 14150357
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ISOTOPIC STUDY OF THE MECHANISM OF ACTION OF ALDOSTERONE ANTAGONISTS].
    SIEGENTHALER W, GFELLER J, MANN M.
    Helv Med Acta; 1964 Nov; 31():610-7. PubMed ID: 14335473
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of the prolonged administration of aldosterone. Antagonistic action of glucocorticoids on the water-salt retention of aldosterone].
    LENZI S, AGNOLI GC, CARIANI A, LODI A, PINELLI G.
    Boll Soc Ital Biol Sper; 1962 Mar 15; 38():241-6. PubMed ID: 14464047
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [THE MODES OF RENAL ACTION OF ALDOSTERONE INHIBITORS. DEDUCTIONS CONCERNING THE POINTS OF ATTACK OF ALDOSTERONE AT THE LEVEL OF THE KIDNEY].
    ROMANI JD, BERNHEIM R, GOOSENS F.
    Ann Endocrinol (Paris); 1963 Mar 15; 24():588-97. PubMed ID: 14051313
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The blocking by spirolactones of the actions of aldosterone and cortisol upon the human kidney.
    MILLS JN, THOMAS S, WILLIAMSON KS.
    J Endocrinol; 1962 Jan 15; 23():357-63. PubMed ID: 14474191
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [CONTRIBUTION TO THE PROBLEM OF IDIOPATHIC EDEMA].
    BOEHM P, FRANKEN FH, IRMSCHER K.
    Klin Wochenschr; 1963 Dec 01; 41():1155-61. PubMed ID: 14114041
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Introduction; spirolactones].
    TRAEGER J.
    Lyon Med; 1961 May 07; 93():1023-7. PubMed ID: 13777813
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.